263 related articles for article (PubMed ID: 29439315)
1. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
2. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
3. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
4. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
6. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
[TBL] [Abstract][Full Text] [Related]
8. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D
J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Guo Y
Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia.
Zhang P; Sun D; Sun X; Li H
Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
Hong Z; Zhang R; Qi H
Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
[TBL] [Abstract][Full Text] [Related]
13. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
15. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
16. Expression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance.
Wang XX; Zhang R; Li Y
Med Sci Monit; 2017 Oct; 23():4768-4778. PubMed ID: 28978904
[TBL] [Abstract][Full Text] [Related]
17. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
[TBL] [Abstract][Full Text] [Related]
18. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
19. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
[TBL] [Abstract][Full Text] [Related]
20. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
J Exp Clin Cancer Res; 2015 Jul; 34(1):68. PubMed ID: 26126974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
